| 1041/1664 | US=23 / Câncer van Diest PJ, Moelans CB, Purnomosari D, Pals G, de Weger RA. Invasive breast cancer: overexpression of HER-2 determined by immunohistochemistry and multiplex ligation-dependent probe amplification. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 291-304. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA INVASIVO; SUPEREXPRESSAO DE HER-2; IMUNOHISTOQUIMICA; LIGADURA MULTIPLEX DEPENDENTE |
| 1042/1664 | US=23 / Câncer Kaufmann M, Loibl S, von Minckwitz G. Operable breast cancer: neoadjuvant treatment (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 305-18. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA OPERAVEL; TRATAMENTO NEOADJUVANTE; CANCER DE MAMA. DIAGNOSTICO; CANCER DE MAMA. TRATAMENTO |
| 1043/1664 | US=23 / Câncer McCubrey JA, Franklin RA, Navolanic PM, Martelli AM, Steelman LS. Chemotherapy for breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 319-25. ISBN 978-1-4020-8368-6. CANCER DE MAMA; QUIMIOTERAPIA; METOTREXATO; 5-FLUOROURACIL; CICLOFOSFAMIDA; ANTRACICLINA; TAXANOS; TRASTUZUMABE; TAMOXIFENO; INIBIDORES DE AROMATASE |
| 1044/1664 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, D'Aiuto M, Comella G. Locally advanced breast cancer: role of chemotherapy in improving prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 327-49. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA LOCALMENTE AVANCADO; QUIMIOTERAPIA; QUIMIOTERAPIA PRE-OPERATORIA; QUIMIOTERAPIA POS-OPERATORIA; TRATAMENTO NEOADJUVANTE; TERAPIA-ALVO |
| 1045/1664 | US=23 / Câncer Kummel S, Rezai M, Kimmig R, Schmid P. Relevance of dose-intensity for adjuvant treatment of breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 351-60. ISBN 978-1-4020-8368-6. |
| 1046/1664 | US=23 / Câncer Pallis AG, Georgoulias V, Mavroudis V. Advanced breast cancer: treatment with docetaxel/epirubicin. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 361-71. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA AVANCADO; CANCER DE MAMA. TRATAMENTO; DOCETAXEL; EPIRRUBICINA; COMBINACAO ANTRACICLINA-TAXANO; COMBINACAO DOCETAXEL EPIRRUBICINA; DADOS FARMACOCINETICOS |
| 1047/1664 | US=23 / Câncer Erban JK, Lau J. Systemic therapy for breast cancer: using toxicity data to inform decisions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 373-94. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TERAPIA SISTEMICA; DADOS DE TOXICIDADE; TERAPIA HORMONAL; QUIMIOTERAPIA; TERAPIAS-ALVO; TOXICIDADE AGUDA; SEQUELAS |
| 1048/1664 | US=23 / Câncer Morabito A, Piccirillo MC, Bryce J, Monaco K, De Feo G, Del Giudice A, Falasconi F, Perrone F. Chemotherapy for metastatic breast cancer patients who received adjuvant anthracyclines (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 395-414. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA METASTATICO; QUIMIOTERAPIA; ANTRACICLINAS ADJUVANTES; HER-2 |
| 1049/1664 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, Thomas R, D'Aiuto M, Comella G. Estrogen receptor-negative and HER-2/neu-positive locally advanced breast carcinoma: therapy with paclitaxel and granulocyte-colony stimulating factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 415-32. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA DE MAMA; ESTROGENIO; RECEPTOR-NEGATIVO; HER-2/NEU-POSITIVE; PACLITAXEL; COLONIAS DE GRANULOCITOS; RECEPTORES HORMONAIS; RESPOSTA A QUIMIOTERAPIA |
| 1050/1664 | US=23 / Câncer Benson JR, Turner EH, Winters Z. Breast cancer: side effects of tamoxifen and anastrozole. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 433-57. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TAMOXIFENO; ANASTROZOL; TERAPIA ANTI-HORMONAL; CANCER DE MAMA AVANCADO; TERAPIA HORMONAL NEOADJUVANTE; TERAPIA HORMONAL ADJUVANTE; QUIMIOPREVENCAO; INIBIDORES DE AROMATASE |
| 1051/1664 | US=23 / Câncer Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6. CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE |
| 1052/1664 | US=23 / Câncer Bafford AC, Garber JE, Chittenden A, Golshan M. Young breast cancer patients undergoing breast-conserving therapy: role of BRCA1 and BRCA2. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 483-91. ISBN 978-1-4020-8368-6. CANCER DE MAMA; PACIENTES JOVENS; TERAPIA CONSERVADORA DA MAMA; BRCA1; BRCA2 |
| 1053/1664 | US=23 / Câncer Smith BD. Radiation therapy for older women with early breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 493-506. ISBN 978-1-4020-8368-6. |
| 1054/1664 | US=23 / Câncer Tan XL, Popanda O, Chang-Claude J. Acute side effects of radiotherapy in breast cancer patients: role of DNA-repair and cell cycle control genes. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 507-28. ISBN 978-1-4020-8368-6. CANCER DE MAMA; RADIOTERAPIA; EFEITOS COLATERAIS; REPARO DO DNA; CELULAS GENES; CONTROLE DE CICLO |
| 1055/1664 | US=35 / Biol/Mol Buchstaller J, Quintana E, Morrison SJ. Cancer stem cells. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 141-54. ISBN 978-1-4160-3703-3. CANCER; CELULAS-TRONCO; CANCER DE TESTICULOS; LEUCEMIA MIELOIDE AGUDA; CANCER DE MAMA; CANCER NO CEREBRO |
| 1056/1664 | US=23 / Câncer Kumar R, Lal N. 18F-Fluorodeoxyglucose/positron emission tomography in primary breast cancer: factors responsible for false-negative results. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 529-41. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TOMOGRAFIA POR EMISSAO DE POSITROS; 18F-FLUORODEOXIGLUCOSE; RESULTADOS FALSO-NEGATIVOS; TAMANHO TUMORAL; TIPO HISTOLOGICO; GRAU DO TUMOR; PADROES DE CRESCIMENTO DE TUMOR; ATIVIDADE PROLIFERATIVA; DENSIDADE DE VASOS SANGUINEOS DO TUMOR; HETEROGENEIDADE DO TECIDO; LESOES DE MAMA UNIFOCAL; LESOES DE MAMA MULTIFOCAL; RECEPTOR DE ESTROGENO; RECEPTOR DE PROGESTERONA; DENSIDADE DA MAMA; PROPAGACAO AXILAR; PROPAGACAO DISTANTE; NIVEIS DE GLICOSE NO SANGUE; TRANSPORTADORES DE GLICOSE; AQUISICAO DE DADOS; ANALISE DE DADOS |
| 1057/1664 | US=35 / Biol/Mol Arrick BA. Breast cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 423-9. ISBN 978-1-4160-3703-3. |
| 1058/1664 | US=23 / Câncer Boughey JC, Bedrosian I. Sentinel lymph node surgery during prophylactic mastectomy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 543-56. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LINFONODO SENTINELA; CIRURGIA; MASTECTOMIA PROFILATICA |
| 1059/1664 | US=23 / Câncer Mack LA, Lindsay RL, Temple WJ. Breast conservation surgery: methods. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 557-68. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CIRURGIA; CONSERVACAO DA MAMA; METODOS CIRURGICOS |
| 1060/1664 | US=23 / Câncer Peiró G. Lymph node-negative breast carcinoma: assessment of HER-2/neu gene status as prognostic value. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 569-81. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LINFONODO NEGATIVO; CARCINOMA DE MAMA; AVALIACAO DA HER-2/NEU; STATUS GENETICO; VALOR PROGNOSTICO; SUPEREXPRESSAO DA PROTEINA; ELISA; IMUNOHISTOQUIMICA; MRNA; AMPLIFICACAO DO GENE |